The enhancer of zeste homolog 2 (EZH2) is elevated in cervical cancer tissues and activates Wnt/β-catenin signaling via the epigenetic silencing of GSK3β and p53 in cancer cells [39]. Here, TP53 is linked to cervical carcinoma.